Abstract:OBJECTIVES(1) To investigate the levels of the serum soluble endothelial growth factor receptor-1 in women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. For more, to analyze the relativity between the levels of the serum soluble vascular growth factor receptor-1 and preeclampsia. (2) To detect the expression of the membrane-bound VEGFR-1 protein in the placenta tissue of the women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia, Then to analyze the relativity between the expression of the membrane-bound endothelial growth factor receptor-1 and preeclampsia.METHODS(1) The serum levels of sVEGFR-1 in 10 women with mild preeclampsia, 10 women with severe preeclampsia, 10 women with eclampsia, 10 women without preeclampsia were detected by the quantitative sandwich enzyme immunoassay technique. (2) Immunohistochemistry and quantitative analysis were used to detect membrane-bound VEGFR-1 contents and distribution in the placenta tissue.RESULTS(1) The results showed that the serum sVEGFR-1 levels of all preeclampsia groups were relatively higher than those of control group (P < 0.05) and that there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. (2) In placentas, the positive staining was detected predominantly in the membranes of villus syncytiotrophoblast cells, extravillous trophoblast cells, and villus endothelial cells. In fetal membranes, the positive staining was detected predominantly in amnionic endothelial cells. (3) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group. There were significant differences between membrane-bound VEGFR-1 contents of the mild preeclampsia,severe preeclampsia and eclampsia (P < 0.05). (4) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/ membrane-bound VEGFR-1) was relatively higher than that of control group (P < 0.05) and there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia (P < 0.05).CONCLUSIONS(1) The serum sVEGFR-1 levels of preeclampsia groups were relatively higher than those of control group, the VEGFR-1 may be related to preeclampsia. (2) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group, the membrane-bound VEGFR-1 may relate to preeclampsia. (3) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/membrane-bound VEGFR-1) was relatively higher than that of control group, the preeclampsia may contribute to VEGFR-1/ PLGF and sVEGFR-1/membrane-bound.

Significance of vascular endothelial growth factor expression in renal tissue of patients with preeclamptic nephropathy.

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

Vascular Endothelial Growth Factor Attenuates N Omega-Nitro-L-Arginine Methyl Ester-Induced Preeclampsia-Like Manifestations In Rats

Expression and clinical implication of endothelial glycoprotein,vascular endothelial growth factor and its receptor 1 in preeclampsia

The expressions and significances of VEGF and p53 in placenta of normal pregnancy and pre-eclampsia patients

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

[The Relativity of Vascular Endothelium Growth Factor Receptor-1 and Preeclampsia].

Significance of vascular endothelial growth factor level in maternal/fetal interface of pregnant women with pregnancy-induced hypertension

Expression and Significance of Mir155 and Vascular Endothelial Growth Factor in Placenta of Rats with Preeclampsia

Relationship of angiostation and VEGF and preeclampsia

The correlation of VEGF expression with MVD in renal pelvic carcinoma and its clinical significance

The Expression of Serum Segfr, Sflt-1, Sendoglin and PLGF in Preeclampsia

Altered Expression of Vascular Endothelial Growth Factor and Its Receptor in the Kidneys of Patients with Type 2 Diabetic Bnephropathy

Predictive and Diagnostic Value of the Angiogenic Proteins in Patients With Chronic Kidney Disease

Effect of Serum of Preeclampsia on Apoptosis of Vascular Endothelial Cells and Expression of Cytokines

The effect of preeclampsia on long-term kidney function among pregnant women with chronic kidney disease

[Expression and Clinical Significance of Platelet-Derived Growth Factor A in Placenta of Pre-Eclampsia.].

Investigation on the expression of tissue kallikrein and kininogen in pre-eclamptic placenta.

[Expression of Vascular Endothelial Growth Factor is Related to Microvessel Injury of Renal Interstitium in Children with Henoch Schönlein Purpura Nephritis].

Expression of VEGF in Kidney of Diabetic Rats